Skip to main content
BIONIME logo

BIONIME — Investor Relations & Filings

Ticker · 4737 ISIN · TW0004737002 TW Manufacturing
Open in API
Filings indexed 1,740 across all filing types
Latest filing 2022-07-15 Director's Dealing
Country TW Taiwan
Listing TW 4737

About BIONIME

www.bionime.com

Bionime Corporation is a biotechnology firm specializing in the research, design, and manufacturing of comprehensive blood glucose management systems. The company develops high-precision monitoring solutions for both personal home use and professional medical environments, including Blood Glucose Meters (BGM), Continuous Glucose Monitoring Systems (CGM), and Point-of-Care Testing (POCT). Under its proprietary brand, RIGHTEST, Bionime integrates medical, chemical, electronic, and precision machinery expertise to deliver products that rival international standards. A core component of its offering is a cloud-based management ecosystem powered by IoT digital solutions, which synchronizes medical data with patient care services. With over 480 core patents in CGM technology and a commitment to Industry 4.0 smart production, Bionime focuses on enhancing diabetes care through technical innovation and a human-centered approach to health monitoring.

Recent filings

Filing Released Lang Actions
111年06月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, managers, and their related parties. It shows changes in shareholdings, types of shares held, and other related information. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate announcements. There is no indication of it being a full financial report, earnings release, or regulatory announcement about voting or dividends. The document is a report of personal share transactions and holdings by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is substantial and contains detailed data, confirming it is the report itself, not just an announcement.
2022-07-15 Chinese
111年6月營業收入
Regulatory Filings Classification · 90% confidence The document is a revenue summary report for a company named 華廣 for the period 民國111年06月 (June 2022). It contains monthly and cumulative net operating revenue figures, percentage changes compared to the previous year, and explanations for revenue changes. The document is short (806 characters) and provides financial data but is not a full financial report like an annual or interim report. It appears to be a regulatory disclosure of revenue figures rather than a comprehensive financial statement or earnings release. Given the nature of the data and the context, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-07-08 Chinese
111年6月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (華廣) reporting on the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements or analysis, nor does it mention any report publication or certification. The content is a regulatory disclosure of financial status related to guarantees and loans, typical of a Regulatory Filing (RNS) category. The document length is short and it does not represent a full report or announcement of a report publication, so it is not an Annual Report, Interim Report, or Report Publication Announcement. Therefore, the best fit is Regulatory Filings (RNS).
2022-07-08 Chinese
111年年報及股東會資料 — 2022_4737_20220622F14.pdf
Governance Information Classification · 95% confidence The document is titled '取得及處分資產處理程序' (Procedures for Acquisition and Disposal of Assets) and contains detailed internal procedures and regulatory compliance guidelines related to the acquisition and disposal of various types of assets, including fixed assets, securities, intangible assets, derivatives, and related-party transactions. It references specific laws such as the Securities Exchange Act and regulations from the Financial Supervisory Commission (金管會). The document includes procedural rules, approval authorities, valuation requirements, disclosure and reporting obligations, and penalties for non-compliance. It is a comprehensive internal procedural manual rather than a financial report, earnings release, or announcement. It does not contain financial statements or results but rather governance and compliance procedures related to asset transactions. Therefore, it fits best under the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2022-07-08 Chinese
111年年報及股東會資料 — 2022_4737_20220622F05.pdf
AGM Information Classification · 100% confidence The document is a detailed record of the Annual General Meeting (AGM) of 華廣生技股份有限公司 held on June 22, 2022 (Republic of China year 111). It includes attendance details, chairman's speech, reports on the previous fiscal year (110th year) business report, auditor's report, employee and director remuneration, profit distribution, amendments to company articles, election of directors including independent directors, and other shareholder meeting resolutions. The document also contains attachments such as the business report, auditor's report, and financial statements for the fiscal year 110 (2021). The content is typical of an AGM minutes document, which records the proceedings and resolutions of the shareholders' meeting. It is not a standalone annual report (10-K), audit report (AR), or earnings release (ER), but rather the official minutes and materials of the AGM. Therefore, the appropriate classification is AGM Information (AGM-R). The document length and detail confirm it is the meeting record itself, not just an announcement or summary.
2022-07-08 Chinese
111年年報及股東會資料 — 2022_4737_20220622F01.pdf
AGM Information Classification · 95% confidence The document is a detailed notice for an Annual General Meeting (AGM) of a company, including the date, location, agenda items such as reports, approvals, discussions, elections, and other shareholder meeting procedures. It also includes information about proxy solicitation, voting procedures, dividend distribution, and candidate lists for board elections. The content is focused on the meeting logistics and shareholder voting instructions rather than the actual annual report or financial statements. The document is not a full annual report (10-K), nor is it a voting results announcement (DVA), but rather the meeting notice and related materials. Therefore, it fits the category of AGM Information (AGM-R). The document length is substantial and contains detailed meeting information, supporting a high confidence classification.
2022-07-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.